The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 28259840 |
83 |
Quinazoline derivatives as selective CYP1B1 inhibitors. |
Birla Institute Of Technology |
| 28222316 |
165 |
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines. |
De Montfort University |
| 27265259 |
16 |
Aryl morpholino triazenes inhibit cytochrome P450 1A1 and 1B1. |
Whittier College |
| 26222195 |
56 |
A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2. |
Xavier University Of Louisiana |
| 25799264 |
94 |
Design and Synthesis of Newa-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression. |
Shanghai Jiao Tong University |
| 25089810 |
79 |
Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia. |
National Taiwan University |
| 23806553 |
7 |
Discovery of triazines as potent, selective and orally active PDE4 inhibitors. |
Biocrea |
| 23600958 |
57 |
Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1. |
Xavier University Of Louisiana |
| 16248836 |
154 |
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity. |
F. Hoffmann-La Roche |
| 22863525 |
36 |
Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1. |
Poznan University Of Medical Sciences |
| 18462007 |
7 |
Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara. |
Universidade Federal De Minas Gerais |
| 17544277 |
29 |
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. |
University Of Maryland |
| 12852960 |
48 |
Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1. |
National Research Institute Of Chinese Medicine |
| 22266038 |
55 |
Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis. |
Astrazeneca |
| 22079757 |
13 |
Discovery of a novel class of aldol-derived 1,2,3-triazoles: potent and selective inhibitors of human cytochrome P450 19A1 (aromatase). |
Mcmaster University |
| 21482471 |
28 |
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids. |
University Of Crete |
| 21411321 |
28 |
Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate. |
Merck Research Laboratories |
| 20813430 |
5 |
Homology modeling and molecular dynamics of CYP1A1 and CYP2B1 to explore the metabolism of aryl derivatives by docking and experimental assays. |
Instituto PolitéCnico Nacional |
| 20696580 |
54 |
Selective inhibition of methoxyflavonoids on human CYP1B1 activity. |
University Of Shizuoka |
| 16631366 |
26 |
Modulators of the human CCR5 receptor. Part 3: SAR of substituted 1-[3-(4-methanesulfonylphenyl)-3-phenylpropyl]-piperidinyl phenylacetamides. |
Astrazeneca |
| 11754588 |
39 |
Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors. |
Seoul National University |
| 28535350 |
3 |
Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells. |
H�Pital Saint-Fran�Ois D'Assise |
Search and Browse
